Adolescent and young adult (AYA) patients with acute lymphoblastic leukemia (ALL) face significant survival disparities and ...

An international clinical trial shows an innovative CAR-T cell immunotherapy is promising against aggressive T cell cancers and has manageable side effects.

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, ...

Allogeneic CAR-T cell therapy is produced using CRISPR gene editing from cells donated by healthy individuals.

Researchers sought to determine whether the ALL-Hematotox would be able to predict hematotoxicity for patients with B-ALL who are at risk of severe hematotoxicity following CAR-T therapy.

An international clinical trial led by WashU Medicine researchers shows an innovative CAR-T cell immunotherapy is promising ...

Our immune system is designed to protect us by recognizing and attacking infected or abnormal cells. However, cancer cells ...

The monumental achievement, in collaboration with Ernest McCulloch, opened the door to regenerative medicine and its ...

Despite failing to achieve MRD-negativity after induction, patients with Ph+ acute lymphoblastic leukemia treated with ...

Sarvodaya Hospital, Faridabad Becomes India’s First Theranostics Center to Offer Terbium-161 PSMA Therapy for Advanced Prostate Cancer Patients ...

Some studies suggested that declining levels of taurine, an amino acid, might be a key driver of aging. But a new study ...

Mason Whitney, a standout high school hockey and lacrosse player from Fairfield, was diagnosed with Acute Myeloid Leukemia in ...